Patents Assigned to Omnicorder Technologies
  • Detection of cancerous lesions by measuring nitric oxide concentrations in tissue
    Patent number: 6035225
    Abstract: The present invention involves the measurement of nitric oxide in interstitial fluid extracted by a thin needle from a body tissue, and particularly a human breast. The diffuse nature of nitric oxide means that the sample of body fluid does not need to be taken directly from the lesion to indicate that cancerous cells are present in the vicinity. Therefore, the presence of nitric oxide in the extracted body fluid is a direct indicator of the presence of a cancerous lesion in the vicinity.
    Type: Grant
    Filed: May 12, 1998
    Date of Patent: March 7, 2000
    Assignee: Omnicorder Technologies
    Inventor: Michael Anbar